CT Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $273K | Buy |
3,934
+1
| +0% | +$69 | 0.17% | 127 |
|
|
2016
Q4 | $233K | Buy |
3,933
+301
| +8% | +$17.8K | 0.15% | 136 |
|
|
2016
Q3 | $241K | Buy |
3,632
+1
| +0% | +$66 | 0.15% | 129 |
|
|
2016
Q2 | $196K | Sell |
3,631
-1,278
| -26% | -$69.1K | 0.12% | 145 |
|
|
2016
Q1 | $254K | Buy |
4,909
+2,449
| +100% | +$127K | 0.14% | 122 |
|
|
2015
Q4 | $173K | Buy |
2,460
+4
| +0.2% | +$281 | 0.1% | 163 |
|
|
2015
Q3 | $153K | Buy |
2,456
+2
| +0.1% | +$124 | 0.1% | 166 |
|
|
2015
Q2 | $206K | Sell |
2,454
-264
| -10% | -$22.2K | 0.12% | 147 |
|
|
2015
Q1 | $204K | Sell |
2,718
-135
| -5% | -$10.1K | 0.11% | 150 |
|
|
2014
Q4 | $177K | Buy |
+2,853
| New | +$177K | 0.13% | 124 |
|
|
2014
Q1 | $204K | Buy |
+2,718
| New | +$204K | 0.11% | 150 |
|